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ATTENTION has been drawn in recent years to the immunological concept of
the aetiology of carcinogenesis (Green, 1961; Law, 1961; Weiler, 1959). The
essential feature ofthese hypotheses is that there is a loss oftissue specific antigens
during carcinogenesis. According to Green (1961a), this deletion may result from
adaptation to an immune response induced against antigenic complexes formed
following interaction of carcinogen with tissue-specific antigens.
In order for such a concept to be meaningful, it is necessary to show that:
1. Modified cell antigens are formed during the early stages of chemical
carcinogenesis.
2. These modified cell antigens can be recognised as " foreign " by the host
and so induce an immune response.
3. There is a loss of cell antigens during the change from a normal to a malig-
nant cell and that this loss results from adaptation to an immune
response evoked by modified cell antigens.
The present paper describes a study of the formation of abnormal tissue
antigens in rat liver during the early stages of 4-dimethylaminoazobenzene
(DMAB) carcinogenesis. This system was selected for investigation since Miller
and Miller (1947) showed that a metabolite of DMAB becomes chemically bound
to liver protein, particularly in the soluble cell sap fraction, during the early
stages of carcinogen feeding. The level of this protein-bound metabolite in
liver reached a maximum after 4 to 6 weeks of carcinogen treatment and there-
after gradually decreased. Although the metabolite could still be detected in
liver even after 20 weeks of carcinogen feeding, none was found in induced liver
tumour. This inability of tumour to bind DMAB to protein and the concurrent
loss of certain cytoplasmic proteins involved in carcinogen binding (Sorof and
Cohen, 1951) has been interpreted as indicating qualitative differences between
the proteins of normal liver and induced tumour.
MATERIALS AND METHODS
Normal rat liver was taken from adult male Wistar rats maintained on a
standard cubed diet with water ad libitum.
DMAB-treated rat liver.-Adult male Wistar rats (250-300 g.) were maintained
on a rice-carrot diet containing 0-06 per cent DMAB. Estimation of the protein
bound metabolite ofDMAB by the procedure ofMiller and Miller (1947) indicated
that the maximal level of carcinogen binding occurred after 4 to 6 weeks feeding
and was comparable to that reported by Miller and Miller (1947) following DMABR. W. BALDWIN
feeding in a semi-synthetic diet. Therefore for immunochemical analysis, liver
was taken from rats maintained on the carcinogen diet for between 4 and 5 weeks.
Liver for control studies was taken from rats fed the basal rice-carrot diet for
similar periods of time.
Preparation of liver cytoplasmic proteinfractions
Rats were killed by cervical dislocation and the livers immediately perfused
with ice-cold buffered saline (0.15 M NaCl-0 01 M Na phosphate, pH 7.4). Livers
were then removed and further processing carried out in a cold room (20 C.).
Following coarse mincing, liver was homogenised in the buffered saline medium
(2 ml./g. wet weight tissue) in an all-glass Potter-Elvehjem homogeniser. Liver
homogenates were centrifuged at 2000 g for 10 minutes to remove cell debris
and nuclei. The soluble cytoplasmic protein fraction (cell sap) was then pre-
pared by centrifuging the supernatant fraction at 20,000 g for 2 hours. Approxi-
mately half of the soluble supernatant was collected and this was re-centrifuged
for a further 2 hours at 20,000 g. The protein content of normal liver cell sap
fractions prepared by this procedure was between 25 to 30 mg./ml., whereas that
of similar fractions from DMAB-treated rat liver was somewhat lower (18 to
22 mg./ml.). Liver cell sap fractions were either utilized immediately or were
rapidly frozen in an alcohol-CO2 bath and stored at -20° C.
Preparation ofAntisera
Antisera were prepared by intramuscular injection of liver protein fractions
in Freund's adjuvant into adult rabbits. A typical immunization schedule con-
sisted ofthree or four injections at 3-weekly intervals ofliver cell sap (15 to 20 mg.
protein) in 2 ml. Freund's adjuvant mixture; 1 ml. being administered into each
hind leg. Rabbits were bled 2 to 3 weeks after the last injection and sera col-
lected in the usual manner. Merthiolate was added to give a final concentration
of 0-01 per cent and antisera were stored at -20° C.
Immunological procedures
Immunochemical analysis of liver cell antigens was carried out using the
Ouchterlony agar gel double diffusion procedure. Agar gels were prepared in
buffered saline (0.15 M NaCl-0-01 M Na phosphate, pH 7.4) containing 0-2 per
cent sodium azide as preservative. Diffusion wells were cut out of the agar gels
by means of a stainless steel cutter and they were filled once with 0-2 ml. of each
reagent. Agar plates were sealed with wax in order to inhibit evaporation from
the wells and incubated at 40 C. At this temperature, precipitation patterns
first became detectable after 4 to 6 days but often required 4 to 5 weeks for com-
plete development.
Preparation of absorbed agar plates
For inhibition studies, agar plates were prepared in which liver protein was
incorporated into the gel. These gels were prepared by adding rapidly with
continuous gentle stirring the liver protein to a 1 per cent agar solution in buffered
saline at 450 C. As soon as the liver protein was completely dispersed, agar
plates were poured at room temperature and when solidified, transferred to a
cold room where all furthermanipulations were conducted. Using thisprocedure,
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it was possible to prepare clear agar gels containing up to 5 mg. liver protein/
ml. agar gel.
Recording of agar gel patterns
Agar plates were examined at 2-3 days intervals and free-hand drawings made
of the diffusion patterns. When it was considered that the diffusion patterns
were fully developed, photographic records were prepared. For this purpose,
agar plates were illuminated by dark-ground illumination and photographic
records obtained on Kodaline K.S.5 sheet film. Additionally washed and dried
agar gels were stained for protein.
RESULTS
Initially, the optimum conditions for the analysis ofthe antigenic composition
of rat liver cell sap were examined. Studies on the effect of temperature of
incubation on agar gel diffusion patterns indicated that reactions conducted at
temperatures greater than 200 C. were unsatisfactory because of non-specific
precipitation of liver protein. Reaction patterns obtained at 40 C. and 100 C.
were comparable although with prolonged incubation, non-specific precipitation
occasionally occurred at 100 C. and therefore agar gel plates were routinely incu-
bated at the lower temperature.
The effect of liver protein concentration was also studied. Rapidly diffusing
antigenic components were more readily detectable at low concentrations of
liver protein (6 to 8 mg./ml.) although a group of components which diffuse only
slowly in agar gel were unresolved at this concentration. Cross-reactions of
normal and DMAB-treated rat liver cell sap fractions failed to reveal any differen-
ces in the rapidly diffusing antigenic components and therefore reactions were
routinely carried out utilizing more concentrated liver protein fractions (15 to
20 mg. protein/ml.). At this concentration, the rapidly diffusing components
became obscured as a halo around the antiserum well and consequently, these
components are not clearly defined.
A typical agar gel cross-reaction pattern of normal (N) and DMAB-treated
(D) rat liver cell sap fractions with antiserum prepared against the DMAB-
treated liver fraction is shown in Fig. 1. Five precipitation lines can be detected
neartothe antiserum well,but these show no abnormalities in their cross-reactions.
In addition, however, a group of two or three poorly resolved precipitation lines
can be detected against the DMAB-treated liver fraction which do not appear to
cross react with components in normal liver cell sap.
Altogether 15 samples ofliver cell sap from rats treated with DMAB for periods
between 4 and 5 weeks have been analysed using a group of 12 antisera prepared
against DMAB-treated rat liver. Abnormal antigenic components were detected
in 11 of these preparations. No differences were detectable between the anti-
genic composition of normal liver cell sap and similar fractions prepared from
rats fed on the basal diet.
Because ofthe poor resolution ofthe abnormal DMAB-liver precipitation lines,
it was not possible to determine exactly the number of antigenic components
involved. Thus in some instances, a group of three sharp lines could be resolved
whereas with other samples, only a single abnormal precipitation line could be
detected.
751R. W. BALDWIN
In Fig. 2, the top triangular pattern shows the cross-reaction of normal and
DMAB-treated liver cell sap fractions with antiserum against the DMAB-treated
fraction. Again the group of abnormal antigenic components in the DMAB-
treated fraction can be clearly seen. The lower triangular pattern (Fig. 2) shows
the cross-reactions of the same liver fractions with antiserum prepared against
normal rat liver cell sap. As can be seen, an apparently abnormal precipitation
line formed against the DMAB-treated liver fraction occurs in approximately
the same position as the abnormal precipitation lines against anti-DMAB-treated
liver cell sap antiserum. Since, however, the antiserum was prepared against
normal liver, the apparently abnormal component in DMAB-treated liver must
be a normal liver antigen, probably present at an elevated concentration. This
result thus suggests that the concentration of at least one normal liver cell sap
antigen is increased during DMAB treatment.
Cro88-reaction in absorbed agar gels
Immunization with DMAB-treated liver cell sap fractions in which normal
liver components are present at greatly increased concentration may result in
the preferential production ofantibodies against these components. It is possible
therefore that the abnormal antigens detected in DMAB-treated liver cell sap
by reaction with homologous antiserum may represent normal liver antigens
present at increased concentration.
In order to confirm the presence of abnormal antigens in DMAB-treated liver
cell sap, immunodiffusion reactions were carried out in agar gels into which was
incorporated one of the antigenic fractions. With the correct conditions, this
results in the suppression ofantibody reacting with the antigens incorporated into
the agar gel as a precipitation band around the antiserum well. Non-reacting
antibody can diffuse into the gel, however, and is thus available for reaction
with antigen.
The precipitation reactions obtained with normal and DMAB-treated liver
cell sap fractions in agar gel into which normal liver cell sap (2 mg. protein/ml.
agar gel) was incorporated are shown in Fig. 3. The amount of normal liver
protein incorporated into the gel was insufficient to completely inhibit antibody
reacting with this fraction, and some normal liver cell sap reactions are still
EXPLANATION OF PLATE.
FIa. 1.-Cross-reaction of normal (N) and DMAB-treated (D) rat liver cell sap fractions with
antiserum prepared against the DMAB-treated fraction (anti-D).
FIG. 2.-Comparison of the cross-reaction patterns of normal (N) and DMAB-treated (D)
liver cell sap with antisera prepared against the normal (anti-N) and DMAB-treated
(anti-D) fractions.
FIG. 3.-Cross-reaction of normal (N) and DMAB-treated (D) liver cell sap with anti-liver
cell sap antisera (cf. Fig. 2) in agar gel absorbed with normal liver cell sap (2 mg. protein/ ml.
agar gel.).
FIG. 4.-Reaction of synthetic DMAB-protein conjugates with antiserum prepared against
DMAB-bovine serum albumin (anti-D. BSA).-
D-BSA/I DMAB-bovine serum albumin (1 mg./ml.).
D-BSA/2 DMAB-bovine serum albumin (0 1 mg./ml.).
D.Bgg. DMAB-bovine-y-globulin (DMAB content equivalent to that of D-BSA/2).
FIG. 5.-Cross-reaction of concentrated DMAB-treated liver cell sap (D-Conc.) with antisera
prepared against DMAB-bovine serum albumin (anti-D. BSA) and the homologous tissue
fraction (anti-D).
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detectable. One strong precipitation line formed by interaction of DMAB-
treated liver cell sap with its homologous antiserum (Fig. 3: Top triangular
pattern) was not affected and here there was no indication of cross-reaction with
a component in the normal liver fraction. In addition, a second reaction line
formed against the DMAB-treated fraction showed some cross-reaction with
normal liver although non-specific precipitation around the well containing normal
liver cell sap rendered interpretation difficult.
The lower triangular pattern (Fig. 3) shows the cross-reaction of the same liver
fractions with antiserum against normal liver cell sap. Here most ofthe antibody
has been inhibited by absorption of the gel with normal liver cell sap. However,
the precipitation line formed close to the well containing DMAB-treated liver is
still formed and this now can be seen to cross-react with a component in normal
liver.
Incorporation of DMAB-treated liver cell sap into agar gels (2-3 mg. protein/
ml. agar gel) completely inhibited any reaction between liver fractions and anti-
sera against the DMAB-treated fraction. A single precipitation line was still
detectable in reactions with antisera against normal liver cell sap although this
showed complete cross-reaction with both normal and DMAB-treated liver cell
sap fractions.
Cross-reaction of DMAB-treated liver cell sap with anti-carcinogen antibody
Since DMAB becomes chemically bound to liver protein, particularly in the
cell sap fraction, during carcinogen feeding, it was considered that the abnormal
antigen detected in DMAB-treated liver may be a normal liver protein modified
by interaction with carcinogen. In order to investigate this hypothesis, use was
made of rabbit antisera prepared against DMAB-protein conjugates. These
protein conjugates were prepared by reaction of 4'-isocyanato-4-dimethylamino-
azobenzene with bovine serum albumin and contained 65 moles DMAB/mole
protein (DMAB-BSA-65; Baldwin, Beswick, Chayen and Cunningham, 1960).
Rabbit antisera against these conjugates contained antibody directed mainly
against the homologous DMAB-BSA-65 conjugate.
In addition, some antibody was directed against the DMAB-prosthetic group.
This is illustrated in Fig. 4 which shows the cross-reaction of the antiserum with
DMAB-BSA-65 and also with a heterologous protein conjugate, DMAB-bovine
y globulin (DMAB-BGG). Bovine y globulin itself did not react with this
antiserum.
Reaction ofthis antiserum with DMAB-treated liver cell sap at normal protein
concentration (20-25 mg./ml.) was inconclusive. However, the amount of
protein-bound DMAB in these fractions is only of the order of 10-20 ,ug./100 mg.
protein and therefore the amount ofmaterial applied to the agar gels was probably
insufficient. In order to increase the amount of protein-bound DMAB applied
to agar gels, liver cell sap fractions were concentrated 3 to 5 fold to approximately
80 mg. protein/ml. by ultradialysis. The majority of precipitation lines observed
in reaction with anti-DMAB treated liver cell sap antiserum are obscured at such
high concentrations of liver protein. In addition, there is considerable non-
specific precipitation of liver protein in agar gel. However, as shown in Fig. 5
a slowly diffusing antigenic component in DMAB-treated liver cell sap cross-
reacts with anti-DMAB-BSA-65 antiserum. Normal liver cell sap at this protein
concentration showed no reaction with this antiserum.
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DISCUSSION
Metabolites of the carcinogenic aminoazo dyes become chemically bound
in vivo to protein in rat liver during the early stages of carcinogenesis (Miller and
Miller, 1947). Although protein-bound carcinogen is found in all sub-cellular
fractions, the major component is contained in the soluble cell sap fraction and
the proteins involved have been identified by moving boundary electrophoresis
(Sorof and Cohein, 1951).
That alterationi of the antigenic properties of protein results from chemical
modification has long been known from the classical studies ofLandsteiner (1945).
More recently, it has been shown that chemical conjugation of protein with
carcinogenic hydrocarbons and aminostilbenes (Creech, Havas and Andre, 1955)
and DMAB (Baldwin, Beswick, Chayen and Cunningham, 1960) results in modi-
fication of the antigenicity of the protein. Similarly, Sri Ram and Maurer
(1957) showed that mild acetylation of rabbit serum albumin induced sufficient
chemical modification to render the protein antigenic for rabbit. The formation
of abnormal antigens following in vivo modification of normal body constituents
is also well documented (Dameshek, Schwartz and Oliner, 1961 ; Waksman,
1962). Depending therefore upon the extent and nature of the in vivo binding
of DMAB to liver protein, it is conceivable that this will result in antigenic modi-
fication of the proteins involved and perhaps induce abnormal antigenic
determinants.
The present study shows quite clearly that modified antigenic components
are formed in the cell sap fraction of rat liver during the early stages of DMAB
feeding. Because of the low rate of diffusion of these altered antigens in agar gel,
it was not possible, utilizing direct agar gel diffusion techniques, to define the
number of antigens involved nor was it possible to assess completely their degree
ofcross-reaction withnormal liver antigens. However, the finding that apparently
abnormal antigenic components can be detected in DMAB-treated liver cell sap
by interaction with antiserum prepared against normal rat liver cell sap suggests
that some of the differences are due to increase in concentration of normal liver
antigens rather than the formation of abnormal components.
Utilizing an absorption technique it was shown, however, that one of the
abnormal antigenic components in DMAB-treated liver cell sap was not inhibited
even when the amount of normal liver cell sap incorporated into the agar gel
was approximately 30 times the amount of DMAB-treated liver protein utilized
for the reaction. Additionally under these conditions, the precipitation line
formed by interaction of DMAB-treated liver protein with the homologous anti-
serum did not show any cross-reaction with normal liver cell sap. It is thus
concluded that this component represents an abnormal cell sap antigen elicited
as a result of DMAB feeding.
The abnormal antigenic component in DMAB-treated rat liver cell sap was
also shown to cross-react with antiserum against synthetic DMAB-bovine albumin
conjugates whereas normal liver fractions showed no reaction. Since this anti-
serum contained antibody directed specifically against the DMAB prosthetic
group, it is concluded that the abnormal antigen in DMAB-treated rat liver cell
sap contains protein bound carcinogenor a metabolite still retaining an azobenzene
structure.
In previous studies from the Russian School (reviewed by Zilber, 1958) it has
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been shown that abnormal liver antigens are formed in mice during the early
period of treatment with o-aminoazotoluene (O-AAT). Thus Korosteleva
(1951, 1957) showed by means of the technique of anaphylaxis with specific
desensitization that an abnormal antigen was present in a soluble protein fraction
of liver from mice receiving O-AAT for one month but not in control, basal diet
fed, mice. This abnormal liver antigen was also considered to contain bound
carcinogen since it was shown that liver protein antigens from mice fed O-AAT
were capable of evoking a direct anaphylactic reaction with the free carcinogen
(Korosteleva, 1951).
These findings have been confirmed by Gel'shtein (1958) who showed, using
the anaphylaxis technique, that O-AAT treated mouse liver contained two
abnormal antigenic components, one of which reacted with a colloidal suspension
of O-AAT in normal liver protein and thus was considered to possess some speci-
ficity towards the carcinogen.
Further evidence supporting the concept of antigenic modification following
carcinogen-tissue interaction has been reported by Green and Anthony (Green,
1959, 1961b). Utilizing the Schultze-Dale procedure they showed that skin
from dibenzanthracene treated mice contained soluble protein antigen(s) which
will react with antibody on the surface of the uteri from mice injected subcu-
taneously with carcinogen.
The present findings clearly indicate that feeding ofDMAB induces significant
alterations in the antigenic composition of rat liver cell sap and at least one
abnormal antigen containing bound carcinogen is formed. Additionally it has
been shown (Baldwin, 1961) that circulating liver cell sap antigens can be detected
in serum for some time following induction of acute liver necrosis in rats with
nitrosodimethylamine. Thus it is likely that liver cell degeneration and necrosis
occurringduringDMAB carcinogenesis will also result in thereleaseoftheabnormal
DMAB-bound liver antigens so that the induction of an immune response to
these components is possible.
There is now considerable evidence of loss of cell sap and microsomal liver
antigens in DMAB-induced liver tumour (Baldwin, 1962) and it is tempting to
speculate whether such deletions may result from an immune response to cell
antigens modified by interaction in vivo with carcinogen. Whether a specific
immune response is elicited to in vivo formed DMAB-liver protein complexes
and the possible effect of such an immune response are still matters for investiga-
tion. There is, however, considerable evidence that autoimmunization, particu-
larly where cellular sensitization occurs, can produce lesions in a variety oftissues
(Waksman, 1962).
SUMMARY
1. Immunochemical analysis of rat liver cell sap has shown that significant
changes in antigenic composition occur during the early stages of DMAB carcino-
genesis.
2. In addition to changes in concentration of normal antigenic components,
at least one abnormal antigen can be detected in DMAB-treated rat liver cell
sap which does not cross-react with normal liver antigens.
3. Antigenic components in DMAB-treated liver cell sap cross-react with
antiserum prepared against synthetic DMAB-bovine albumin conjugates. This
antiserum contains antibody directed specifically against the DMAB prosthetic
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group, and so it is concluded that the abnormal antigens in DMAB-treated liver
cell sap contain bound carcinogen.
4. The implication of these findings is discussed in relation to the immuno-
logical concept of chemical carcinogenesis.
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